Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Exchange Rate Effect (2023 - 2025)

Rhythm Pharmaceuticals (RYTM) has disclosed Exchange Rate Effect for 3 consecutive years, with $64000.0 as the latest value for Q4 2025.

  • Quarterly Exchange Rate Effect fell 93.45% to $64000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $87000.0 through Dec 2025, up 4250.0% year-over-year, with the annual reading at $87000.0 for FY2025, 4250.0% up from the prior year.
  • Exchange Rate Effect for Q4 2025 was $64000.0 at Rhythm Pharmaceuticals, down from $304000.0 in the prior quarter.
  • The five-year high for Exchange Rate Effect was $977000.0 in Q4 2024, with the low at -$603000.0 in Q3 2024.
  • Average Exchange Rate Effect over 3 years is -$4416.7, with a median of -$36500.0 recorded in 2024.
  • Peak annual rise in Exchange Rate Effect hit 608.85% in 2024, while the deepest fall reached 883.12% in 2024.
  • Over 3 years, Exchange Rate Effect stood at -$192000.0 in 2023, then skyrocketed by 608.85% to $977000.0 in 2024, then plummeted by 93.45% to $64000.0 in 2025.
  • According to Business Quant data, Exchange Rate Effect over the past three periods came in at $64000.0, $304000.0, and -$279000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.